COMPANY PROFILE

LQ3 Pharmaceuticals

Explore full profile

LQ3 Pharmaceuticals, Inc operates in the healthcare industry focusing on pharmaceutical business

Morrisville, United StatesFounded 2014Biotech & Life Sciences

Valuation $50–100M Last recorded · 2014

Total funding $10–50M Disclosed equity funding

Unlock exact values

About LQ3 Pharmaceuticals

LQ3 Pharma operates an online platform that provides detailed reviews and comprehensive information on both generic and brand-name medications. The company serves consumers looking for reliable information to make informed decisions about their pharmaceutical purchases. Operating in the online pharmacy review market, LQ3 Pharma aggregates data from medical experts and user reviews to offer insights into the efficacy, side effects, and overall performance of various drugs. The business model is based on providing free access to this information, potentially monetizing through partnerships, advertising, or affiliate marketing with online pharmacies. By offering a user-friendly interface and detailed drug descriptions, LQ3 Pharma aims to simplify the decision-making process for consumers, ensuring they have all the necessary information to choose the right medication.

MoreLess Source: Dealroom company data

At a glance

Status: Closed
Founded: 2014
Headquarters: Morrisville, United States
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Sep 2014	$10M	$40M	Envisia Therapeutics · Canaan · Correlation Ventures	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

LQ3 Pharmaceuticals website traffic

Latest recorded traffic for LQ3 Pharmaceuticals is 50 monthly website visits.

Latest monthly visits50

Monthly website visitsOct 2017–Aug 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AFAlpha FusionFusion of leading-edge scientists teaming in Nuclear Physics, Organic Chemistry, and Nuclear Medicine	Osaka, Japan	Operational	—	$12M	$31M
TTTeitur TrophicsCyclic peptide therapeutics for neurodegenerative diseases	Aarhus, Denmark	Operational
TTTay TherapeuticsBiotech platform enhancing patient-specific medicines through advanced discovery and development expertise	Dundee, United Kingdom	Operational
EBExeVir BioCamelid-derived antibody therapies for infectious diseases	Ghent, Belgium	Operational
CTCV6 TherapeuticsCombination therapies enhancing cornerstone cancer and inflammatory treatments	Belfast, United Kingdom	Operational
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational
RBRosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology	Bristol, United Kingdom	Operational
ASAstronauTxSmall-molecule therapeutics targeting astrocytes for neurodegenerative diseases	Reading, United Kingdom	Operational